Summary
President Donald Trump is expected to sign an order to change the classification of cannabis in the United States. This change would move cannabis from a Schedule I drug to a Schedule III drug, making it similar to Tylenol with codeine. The reclassification could allow more research into cannabis and have tax implications for dispensaries.
Key Facts
- President Trump plans to sign an order to reclassify cannabis from a Schedule I to a Schedule III drug.
- Schedule I drugs are considered to have no accepted medical use and a high potential for abuse.
- As a Schedule III drug, cannabis would be on the same level as some medications that are less strictly controlled.
- This change would allow more research into cannabis and might affect taxes for cannabis businesses.
- Some Republican lawmakers are worried the change might increase cannabis use and impact public health.
- Currently, 24 US states allow cannabis for recreational use, and a majority permit it for medical reasons.
- The Drug Enforcement Agency says Schedule III drugs have a moderate to low chance of dependence.
- Polls show most Americans support legalizing marijuana.
